Cargando…

745. Surveillance for Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus Infections During 2016–2017 and 2017–2018, United States

BACKGROUND: Three neuraminidase inhibitors (NAIs) are approved and recommended for treatment of influenza in the United States; however, antiviral resistance can emerge during or after treatment, and sporadic resistant viruses unrelated to NAI exposure may occur, especially in influenza A(H1N1)pdm09...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spencer, Sarah, Nguyen, Ha, Elal, Anwar Abd, Laplante, Jennifer, George, Kirsten St, Fry, Alicia M, Gubareva, Larisa, Campbell, Angela P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255555/ http://dx.doi.org/10.1093/ofid/ofy210.752

Ejemplares similares

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2015)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017
por: Kyaw Win, Su Mon, et al.
Publicado: (2020)

Update: Influenza Activity — United States, October 2, 2016–February 4, 2017
por: Blanton, Lenee, et al.
Publicado: (2017)

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014
por: Trebbien, Ramona, et al.
Publicado: (2017)

Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015–2016 season in Japan
por: Hibino, Akinobu, et al.
Publicado: (2016)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
por: Graitcer, Samuel B., et al.
Publicado: (2011)

Prevalence of Influenza A(H1N1)pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012 - 2013
por: Khodadad, Nastaran, et al.
Publicado: (2015)

Update: Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine
por: Blanton, Lenee, et al.
Publicado: (2017)

Update: Influenza Activity — United States, October 1, 2017–February 3, 2018
por: Budd, Alicia P., et al.
Publicado: (2018)

Molecular characterization of influenza A(H1N1)pdm09 viruses circulating at various geographical locations in India, 2017
por: Potdar, Varsha, et al.
Publicado: (2019)

Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009–2010
por: Bashir Aamir, Uzma, et al.
Publicado: (2012)

Antigenic Site Variation in the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09 Viruses between 2009–2017 in Ukraine
por: Zolotarova, Oksana, et al.
Publicado: (2019)

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia
por: Hurt, A. C., et al.
Publicado: (2012)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013–2014 influenza season in Mainland China
por: Huang, Weijuan, et al.
Publicado: (2015)

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2014)

Update: Influenza Activity — United States, October 1–November 25, 2017
por: Dugan, Vivien G., et al.
Publicado: (2017)

Delayed emergence of oseltamivir‐resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar
por: Dapat, Clyde, et al.
Publicado: (2012)

Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses
por: Al Farroukh, Mohammad, et al.
Publicado: (2022)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
por: Storms, Aaron D., et al.
Publicado: (2012)

Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
por: Garten, Rebecca, et al.
Publicado: (2018)

Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research
por: Kiseleva, Irina, et al.
Publicado: (2020)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Impacts du nouveau règlement 2017/745 sur la gestion biomédicale des dispositifs médicaux
por: Boissart, V.
Publicado: (2021)

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
por: Kissling, Esther, et al.
Publicado: (2019)

Adults With Diabetes Hospitalized With Pandemic Influenza A(H1N1)pdm09—U.S. 2009
por: Ganatra, Rahul B., et al.
Publicado: (2013)

Missed detections of influenza A(H1)pdm09 by real-time RT–PCR assay due to haemagglutinin sequence mutation, December 2017 to March 2018, northern Viet Nam
por: Hoang Vu Mai, Phuong, et al.
Publicado: (2019)

Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons
por: Monamele, Chavely Gwladys, et al.
Publicado: (2019)

Hospital-based surveillance of influenza A(H1N1)pdm09 virus in Saudi Arabia, 2010-2016
por: Abdalla, Osman, et al.
Publicado: (2020)

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity
por: Vidaña, Beatriz, et al.
Publicado: (2020)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Compliance to Oseltamivir among Two Populations in Oxfordshire, United Kingdom Affected by Influenza A(H1N1)pdm09, November 2009 – A Waste Water Epidemiology Study
por: Singer, Andrew C., et al.
Publicado: (2013)

CERN Bulletin Issue No. 09-10/2017
Publicado: (2017)

Neurological events related to influenza A (H1N1) pdm09
por: Cárdenas, Graciela, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_atg15n8erehid229rda68998qp